The effect of mycophenolate mofetil on disease development in the gld.apoE (-/-) mouse model of accelerated atherosclerosis and systemic lupus erythematosus.
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease that is characterized by autoantibody production and inflammatory disease involving multiple organs. Premature atherosclerosis is a common complication of SLE and results in substantial morbidity and mortality from cardiovascular di...
Main Authors: | Christophe Richez, Rocco J Richards, Pierre Duffau, Zachary Weitzner, Christopher D Andry, Ian R Rifkin, Tamar Aprahamian |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2013-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3620051?pdf=render |
Similar Items
-
Mycophenolate mofetil and atherosclerosis
by: Z S Alekberova, et al.
Published: (2009-10-01) -
Response to mycophenolate mofetil therapy in the patient with severe systemic lupus erythematosus
by: Božić-Majstorović Ljubinka, et al.
Published: (2016-01-01) -
Mycophenolate Mofetil (MMF) for the treatment of juvenile onset systemic lupus erythematosus
by: Falcini FF, et al.
Published: (2008-09-01) -
Effects of Mycophenolate Mofetil on Cutaneous Lupus Erythematosus in Mouse Animal Model
by: Hui-Ying, Lin, et al.
Published: (2011) -
Mycophenolate mofetil in the treatment of lupus nephritis
by: Patrick FK Yong, et al.
Published: (2008-06-01)